Skip to main content
SpringerLink
Log in

Insulin Aspart

A Viewpoint by Philip Home

  • Adis New Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Data on file, Novo Nordisk A/S, with permission

  2. Zinman B, Tildesley H, Chaisson J-L, et al. Insulin lispro in CSII: results of a double-blind crossover study. Diabetes 1997; 46: 440–443

    Article  PubMed  CAS  Google Scholar 

  3. Home PD. Insulin glargine: the first clinically useful extended-acting insulin in half a century? Exp Opin Invest Drugs 1999; 8: 307–314

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Newcastle upon Tyne, UK

    Philip Home

Authors
  1. Philip Home
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Home, P. Insulin Aspart. Drugs 57, 767 (1999). https://doi.org/10.2165/00003495-199957050-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199957050-00015

Search

Navigation